Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Absorptiometry, Photon | 27 | 2024 | 110 | 5.170 |
Why?
|
| Spinal Fractures | 20 | 2024 | 103 | 5.170 |
Why?
|
| Bone Density | 32 | 2025 | 239 | 5.170 |
Why?
|
| Osteoporotic Fractures | 9 | 2024 | 53 | 4.560 |
Why?
|
| Hypoparathyroidism | 16 | 2025 | 26 | 4.290 |
Why?
|
| Osteoporosis | 15 | 2022 | 131 | 4.040 |
Why?
|
| Cancellous Bone | 6 | 2022 | 20 | 2.940 |
Why?
|
| Parathyroid Hormone | 16 | 2025 | 228 | 2.870 |
Why?
|
| Fractures, Bone | 5 | 2024 | 155 | 1.760 |
Why?
|
| Hormone Replacement Therapy | 8 | 2022 | 97 | 1.640 |
Why?
|
| Calcaneus | 6 | 2013 | 41 | 1.540 |
Why?
|
| Hip Fractures | 3 | 2023 | 51 | 1.510 |
Why?
|
| Lumbar Vertebrae | 11 | 2021 | 363 | 1.410 |
Why?
|
| Body Composition | 3 | 2022 | 75 | 1.370 |
Why?
|
| Quality of Life | 10 | 2025 | 1816 | 1.190 |
Why?
|
| Vitamin D | 14 | 2025 | 273 | 1.110 |
Why?
|
| Femur Neck | 10 | 2024 | 44 | 1.060 |
Why?
|
| Risk Assessment | 10 | 2024 | 2480 | 1.010 |
Why?
|
| Osteoporosis, Postmenopausal | 6 | 2014 | 33 | 0.840 |
Why?
|
| Electronic Health Records | 2 | 2024 | 372 | 0.810 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 771 | 0.790 |
Why?
|
| Aged | 34 | 2025 | 20968 | 0.790 |
Why?
|
| Calcium | 14 | 2025 | 1205 | 0.790 |
Why?
|
| Middle Aged | 35 | 2025 | 28368 | 0.770 |
Why?
|
| Female | 48 | 2025 | 50028 | 0.750 |
Why?
|
| Diabetes Complications | 2 | 2020 | 175 | 0.740 |
Why?
|
| Densitometry | 4 | 2015 | 28 | 0.720 |
Why?
|
| Humans | 67 | 2025 | 96105 | 0.700 |
Why?
|
| Women's Health | 1 | 2022 | 109 | 0.670 |
Why?
|
| Spine | 3 | 2017 | 153 | 0.650 |
Why?
|
| Aged, 80 and over | 16 | 2024 | 7229 | 0.650 |
Why?
|
| Nutrition Surveys | 5 | 2022 | 125 | 0.650 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 38 | 0.640 |
Why?
|
| Wrist Injuries | 1 | 2019 | 14 | 0.620 |
Why?
|
| Humeral Fractures | 1 | 2019 | 25 | 0.610 |
Why?
|
| Male | 36 | 2025 | 45863 | 0.590 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 281 | 0.590 |
Why?
|
| Recombinant Proteins | 7 | 2025 | 1034 | 0.590 |
Why?
|
| Accelerometry | 1 | 2019 | 48 | 0.570 |
Why?
|
| Femur | 2 | 2017 | 108 | 0.570 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 13 | 0.540 |
Why?
|
| Whole Body Imaging | 1 | 2017 | 40 | 0.530 |
Why?
|
| Societies, Medical | 4 | 2015 | 644 | 0.480 |
Why?
|
| Exercise | 1 | 2019 | 354 | 0.470 |
Why?
|
| Adult | 24 | 2025 | 28721 | 0.450 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 2777 | 0.440 |
Why?
|
| Retrospective Studies | 10 | 2024 | 10287 | 0.420 |
Why?
|
| Thoracic Vertebrae | 3 | 2016 | 91 | 0.400 |
Why?
|
| Risk Factors | 10 | 2024 | 5961 | 0.380 |
Why?
|
| Predictive Value of Tests | 6 | 2024 | 1805 | 0.380 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 1876 | 0.360 |
Why?
|
| Glucocorticoids | 5 | 2016 | 369 | 0.330 |
Why?
|
| Diabetes Insipidus | 2 | 2006 | 17 | 0.320 |
Why?
|
| Heart Transplantation | 1 | 2016 | 812 | 0.320 |
Why?
|
| Patient Selection | 2 | 2014 | 709 | 0.320 |
Why?
|
| Hip Joint | 3 | 2018 | 56 | 0.320 |
Why?
|
| Pennsylvania | 2 | 2020 | 101 | 0.310 |
Why?
|
| Vitamin D Deficiency | 2 | 2021 | 107 | 0.310 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2007 | 472 | 0.300 |
Why?
|
| Double-Blind Method | 7 | 2025 | 1791 | 0.300 |
Why?
|
| Frail Elderly | 1 | 2009 | 92 | 0.280 |
Why?
|
| Chicago | 3 | 2024 | 1506 | 0.280 |
Why?
|
| Body Mass Index | 3 | 2022 | 815 | 0.260 |
Why?
|
| Incidence | 3 | 2021 | 1715 | 0.260 |
Why?
|
| Calcium, Dietary | 3 | 2022 | 68 | 0.250 |
Why?
|
| Treatment Outcome | 10 | 2025 | 9175 | 0.250 |
Why?
|
| Radiography | 4 | 2015 | 826 | 0.240 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2025 | 286 | 0.230 |
Why?
|
| Prevalence | 4 | 2016 | 1349 | 0.230 |
Why?
|
| Vasopressins | 4 | 1988 | 50 | 0.220 |
Why?
|
| Calcitriol | 3 | 2020 | 173 | 0.220 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 57 | 0.210 |
Why?
|
| Bone Matrix | 1 | 2003 | 20 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2024 | 630 | 0.200 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2022 | 12 | 0.190 |
Why?
|
| Age Factors | 3 | 2016 | 1963 | 0.190 |
Why?
|
| Bone Density Conservation Agents | 1 | 2022 | 51 | 0.180 |
Why?
|
| Bone and Bones | 1 | 2003 | 280 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 3 | 2022 | 1096 | 0.160 |
Why?
|
| Thirst | 3 | 1988 | 19 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2017 | 1319 | 0.160 |
Why?
|
| Comorbidity | 2 | 2021 | 1011 | 0.160 |
Why?
|
| Abdomen | 1 | 2020 | 127 | 0.160 |
Why?
|
| Logistic Models | 3 | 2010 | 1268 | 0.150 |
Why?
|
| Water-Electrolyte Balance | 3 | 2006 | 70 | 0.150 |
Why?
|
| Pelvic Bones | 1 | 2019 | 45 | 0.140 |
Why?
|
| Chronic Disease | 2 | 2021 | 983 | 0.140 |
Why?
|
| Risk | 1 | 2019 | 668 | 0.140 |
Why?
|
| Mexican Americans | 1 | 2018 | 70 | 0.140 |
Why?
|
| Hip | 1 | 2017 | 18 | 0.140 |
Why?
|
| United States | 4 | 2020 | 7768 | 0.130 |
Why?
|
| Hypocalcemia | 1 | 2017 | 43 | 0.130 |
Why?
|
| Hyperphosphatemia | 1 | 2017 | 25 | 0.130 |
Why?
|
| Clinical Trials as Topic | 2 | 2018 | 1179 | 0.130 |
Why?
|
| Osteocalcin | 1 | 2016 | 26 | 0.130 |
Why?
|
| Alkaline Phosphatase | 1 | 2016 | 136 | 0.120 |
Why?
|
| Registries | 1 | 2021 | 986 | 0.120 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2016 | 45 | 0.120 |
Why?
|
| Parathyroidectomy | 1 | 2016 | 79 | 0.120 |
Why?
|
| Acetabulum | 1 | 2016 | 21 | 0.120 |
Why?
|
| Prednisone | 1 | 2016 | 258 | 0.120 |
Why?
|
| Phosphates | 1 | 2016 | 167 | 0.120 |
Why?
|
| Sensitivity and Specificity | 6 | 2008 | 2039 | 0.120 |
Why?
|
| Artifacts | 1 | 2017 | 252 | 0.120 |
Why?
|
| Disability Evaluation | 1 | 2016 | 171 | 0.120 |
Why?
|
| Health Status | 1 | 2018 | 386 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3927 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 346 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 334 | 0.110 |
Why?
|
| Obesity | 1 | 2022 | 1030 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 1979 | 0.110 |
Why?
|
| Physicians | 1 | 2021 | 707 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 880 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 257 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 169 | 0.090 |
Why?
|
| Prognosis | 1 | 2020 | 4028 | 0.090 |
Why?
|
| Radiographic Image Enhancement | 2 | 2004 | 467 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 3639 | 0.090 |
Why?
|
| Homeostasis | 2 | 2016 | 467 | 0.080 |
Why?
|
| Anthropometry | 1 | 2010 | 78 | 0.080 |
Why?
|
| Age Distribution | 1 | 2010 | 209 | 0.080 |
Why?
|
| Body Height | 1 | 2010 | 108 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2009 | 41 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 60 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 38 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 2860 | 0.070 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 1988 | 16 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 710 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2009 | 132 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 296 | 0.070 |
Why?
|
| Menstrual Cycle | 1 | 1988 | 59 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 216 | 0.070 |
Why?
|
| Illinois | 1 | 2009 | 531 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2009 | 277 | 0.070 |
Why?
|
| Equipment Failure Analysis | 2 | 2004 | 91 | 0.060 |
Why?
|
| Body Water | 1 | 1987 | 35 | 0.060 |
Why?
|
| Parathyroid Glands | 2 | 2017 | 75 | 0.060 |
Why?
|
| Fractals | 1 | 2006 | 42 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2007 | 2880 | 0.060 |
Why?
|
| Antibodies | 1 | 1988 | 356 | 0.060 |
Why?
|
| Estrogens | 2 | 2001 | 203 | 0.060 |
Why?
|
| Camurati-Engelmann Syndrome | 1 | 2004 | 1 | 0.050 |
Why?
|
| Jaw Abnormalities | 1 | 2004 | 1 | 0.050 |
Why?
|
| Decision Making | 1 | 2010 | 694 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2004 | 107 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2005 | 340 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 363 | 0.050 |
Why?
|
| Minerals | 1 | 2022 | 21 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 231 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2004 | 302 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1667 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 3110 | 0.050 |
Why?
|
| Creatinine | 1 | 2022 | 299 | 0.040 |
Why?
|
| Observer Variation | 1 | 2003 | 626 | 0.040 |
Why?
|
| Reference Values | 2 | 2016 | 674 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2022 | 117 | 0.040 |
Why?
|
| Prodrugs | 1 | 2022 | 54 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2021 | 56 | 0.040 |
Why?
|
| Young Adult | 2 | 2013 | 7025 | 0.040 |
Why?
|
| Placebos | 1 | 2022 | 213 | 0.040 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2001 | 10 | 0.040 |
Why?
|
| Calcitonin | 1 | 2001 | 40 | 0.040 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2001 | 48 | 0.040 |
Why?
|
| Diphosphonates | 1 | 2001 | 38 | 0.040 |
Why?
|
| Calcifediol | 1 | 2020 | 22 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2022 | 873 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 79 | 0.040 |
Why?
|
| Vitamins | 1 | 2020 | 86 | 0.040 |
Why?
|
| Forecasting | 1 | 2001 | 317 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1276 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 2017 | 62 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2017 | 133 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 349 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2016 | 71 | 0.030 |
Why?
|
| Animals | 4 | 2009 | 28891 | 0.030 |
Why?
|
| Calcium Citrate | 1 | 2013 | 2 | 0.030 |
Why?
|
| Spasm | 1 | 2013 | 19 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 134 | 0.030 |
Why?
|
| Hand Strength | 1 | 2013 | 63 | 0.030 |
Why?
|
| Back Pain | 1 | 2013 | 76 | 0.030 |
Why?
|
| Headache | 1 | 2013 | 82 | 0.020 |
Why?
|
| Adolescent | 3 | 2013 | 9895 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 4671 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 813 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 594 | 0.020 |
Why?
|
| Smoking | 1 | 2013 | 653 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2009 | 24 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2009 | 76 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 256 | 0.020 |
Why?
|
| Hematocrit | 1 | 1988 | 69 | 0.020 |
Why?
|
| Urea | 1 | 1988 | 60 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 1988 | 44 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 1988 | 169 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 180 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 193 | 0.020 |
Why?
|
| Progesterone | 1 | 1988 | 112 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 5580 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1988 | 151 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2009 | 324 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2009 | 830 | 0.020 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 1987 | 5 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1987 | 27 | 0.020 |
Why?
|
| Hyponatremia | 1 | 1987 | 30 | 0.020 |
Why?
|
| Sodium | 1 | 1988 | 340 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1987 | 88 | 0.020 |
Why?
|
| Body Weight | 1 | 1988 | 460 | 0.020 |
Why?
|
| Child | 2 | 2008 | 7625 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2016 | 2591 | 0.010 |
Why?
|
| Lod Score | 1 | 2004 | 153 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 116 | 0.010 |
Why?
|
| CHO Cells | 1 | 2004 | 196 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 2161 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1988 | 926 | 0.010 |
Why?
|
| Radiometry | 1 | 2004 | 61 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 297 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 422 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 542 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 648 | 0.010 |
Why?
|
| Mice | 2 | 2009 | 12537 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2004 | 623 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2004 | 264 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 908 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 982 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1083 | 0.010 |
Why?
|
| Infant | 1 | 1988 | 3363 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1988 | 3974 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2090 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 3040 | 0.010 |
Why?
|